No Data
No Data
KeyBanc Maintains Absci Corp(ABSI.US) With Buy Rating, Raises Target Price to $9
Absci Is Maintained at Overweight by Keybanc
Express News | Keybanc Maintains Overweight on Absci, Raises Price Target to $9
Absci to Report Business Updates and First Quarter 2025 Financial and Operating Results on May 13, 2025
Nvidia-Backed Recursion, Ginkgo Bioworks Rally Following FDA's Decision To End Animal Testing
Fastenal Posts Better-Than-Expected Sales, Joins Simulations Plus, Certara And Other Big Stocks Moving Higher On Friday